Oral Session 1-8B Pediatric AML

[OS1-8B-4] Recurrent gene mutations in pediatric AML by targeted sequencing using a 343-gene custom panel

Taeko Kaburagi¹, Genki Yamato^1,2,3, Norio Shiba^2,3,4, Kenichi Yoshida⁵, Yusuke Hara^2,3,6, Yuichi Shiraishi⁷, Kentaro Ohki^2,8, Manabu Sotomatsu^1,2, Hirokazu Arakawa⁶, Hidemasa Matsuo⁹, Akira Shimada^2,10, Tomohiko Taki¹¹, Nobutaka Kiyokawa^2,8, Daisuke Tomizawa^2,12, Keizo Horibe^2,3, Satoru Miyano¹³, Souichi Adachi^2,9, Takashi Taga^2,14, Seishi Ogawa⁵, Yasuhide Hayashi^1,3,15 (1.Department of Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan, 2.Japan Children's Cancer Group, 3.Clinical Research Center, Nagoya Medical Center, Aichi, Japan, 4.Department of Pediatrics, Yokohama City University Hospital, Kanagawa, Japan, 5.Dept. of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan, 6.Department of Pediatrics, Gunma University, Gunma, Japan, 7.Div. Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan, 8.Natl. Cent. For Child Health and Dev., Tokyo, Japan, 9.Dept. of Human Health Sciences, Kyoto Univ. Kyoto, Japan, 10.Department of Pediatrics, Okayama University, Okayama, Japan, 11.Department of Medical Technology, Kyorin University, Tokyo, Japan, 12.Div. Leukemia and Lymphoma, Children's Cancer Center, NCCHD, Tokyo, Japan, 13.Lab. of DNA information Analysis, HGC, Tokyo Univ., Tokyo, Japan, 14.Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan, 15.Institute of Physiology and Medicine, Jobu University, Gunma, Japan)